ORIC - ORIC Pharmaceuticals, Inc.
NEXT EARNINGS:
May 4, 2026
EPS Est: $-0.36
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.00
DETAILS
HIGH:
$25.00
LOW:
$15.00
MEDIAN:
$22.00
CONSENSUS:
$21.00
UPSIDE:
56.48%
Market Cap:
1.31B
Volume:
4,663,444
Avg Volume:
1,488,875
52 Week Range:
3.895-14.93
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.33
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
122
IPO Date:
2020-04-24
EPS (TTM):
-1.47
P/E Ratio:
-5.55
Revenue (TTM):
N/A
Total Assets:
408.89M
Total Debt:
N/A
Cash & Equiv:
45.67M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
N/A
Debt/Equity:
N/A
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-23 | $-0.30 | $-0.34 | +11.8% | — | — | — |
| 2025-11-13 | $-0.33 | $-0.41 | +19.5% | — | — | — |
| 2025-08-12 | $-0.47 | $-0.46 | -2.2% | — | — | — |
| 2025-05-05 | $-0.42 | $-0.51 | +17.6% | — | — | — |
| 2025-02-18 | $-0.51 | $-0.52 | +1.9% | $533000 | — | — |
| 2024-11-12 | $-0.49 | $-0.48 | -2.1% | — | — | — |
| 2024-08-12 | $-0.45 | $-0.42 | -7.1% | — | — | — |
| 2024-05-06 | $-0.37 | $-0.44 | +15.9% | — | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (129.47M) | (127.85M) | (100.70M) | (89.12M) | (78.72M) | (73.70M) | (26.88M) | (21.36M) | (22.03M) |
| EPS | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 | -3.36 | -0.85 | -1.12 | -0.74 |
| Total Assets | 408.89M | 274.14M | 254.69M | 250.36M | 298.64M | 299.00M | 94.09M | 46.73M | 30.02M |
| Total Debt | 0 | 3.18M | 10.21M | 12.10M | 1.93M | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 45.67M | 59.41M | 23.38M | 66.84M | 226.01M | 78.45M | 89.16M | 42.64M | 25.82M |
| Operating Cash Flow | (110.97M) | (112.66M) | (85.69M) | (75.14M) | (59.54M) | (45.27M) | (23.53M) | (20.68M) | (20.83M) |
| Free Cash Flow | (110.97M) | (113.85M) | (86.54M) | (77.22M) | (60.48M) | (45.94M) | (24.30M) | (21.21M) | (21.32M) |
| FCF per Share | -1.26 | -1.63 | -1.68 | -1.95 | -1.59 | -2.09 | -0.81 | -1.11 | -0.71 |
| Book Value | 384.36M | 243.12M | 224.09M | 222.35M | 272.98M | 289.78M | 87.97M | (64.43M) | 25.73M |
| Cash & ST Investments | 281.49M | 255.96M | 208.19M | 206.27M | 236.98M | 293.60M | 89.16M | 42.64M | 25.82M |
| ROC Equity | -0.34 | -0.53 | -0.45 | -0.40 | -0.29 | -0.25 | -0.31 | N/A | -0.86 |